Justine Cunningham

Justine Cunningham

Company: Sana Biotechnology

Job title: Vice President Toxicology & Biodistribution

Seminars:

De-risking the Nonclinical Safety Package for Vector Delivered Gene Therapies 9:45 am

 Evaluate current perspectives on safety risks for gene therapies Delve into approaches & strategies to de-risking Case study: species specific toxicities to high doses of human proteinsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.